Autochthonous mucosal leishmaniasis in a hemodialyzed italian patient

New Microbiologica

Volumn 25, Issue 1, 2002, Pages 103-106

  Maggi, P ^a   Larocca, A M V ^a   Mininni, F ^a   Fiorentino, G ^a   Saracino, A L ^a   Chironna, M ^a   Quarto, M ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Hemodialysis; Leishmania

Indexed keywords

ANIMAL; ARTICLE; CASE REPORT; HUMAN; ISOLATION AND PURIFICATION; ITALY; LEISHMANIA INFANTUM; MALE; MIDDLE AGED; PARASITOLOGY; RENAL REPLACEMENT THERAPY; SKIN LEISHMANIASIS;

ANIMALS; HUMANS; ITALY; LEISHMANIA INFANTUM; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0036357528     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. AMATO, V.S., PADILHA, A.R.S., NICODEMO, A.C., DUARTE, M.I.S., VALENTINI, M., UIP, D.E., BOULOS, M., and AMATO NETO, V. (2000). Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study. International Journal of Infectious Diseases, 4, 153-157.
2. ANGARANO, G., MAGGI, P., COPPOLA, S.L., and CAVALIERE, R.L. (1998). Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infectcd patient. European Journal of Clinical Microbiology and Infectious Diseases, 17, 365-367.
3. ASILIAN, A., JALAYER, T., WHITWORTH, J.A., GHASEMI, R.L., NILFOROOSHZADEH, M., and OLLIARO, P. (1995). A randomized, placebocontrolled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. American Journal of Tropical Medicine and Hvgiene, 53, 648-651.
4. DE CARNERI, I. (1986). Leishmaniosi viscerale In: Parassitologia Generale ed Umana I. IX ed. Casa Editrice Ambrosiana, Milano, pp. 103-106.
5. DESJEUX, P. (1992). Human leishmaniases: epidemiology and public health aspects. World Health Statistics Quarterly, 45, 267-275.
6. HERWALDT, B.L. (1999). Leishmaniasis. Lancet, 354, 1191-1199.
7. MAGGI, P., TOMMASI, D., MACI, A.M., GRIMA, P., TUNDO, P., POTENZA, D., LONGOBARDO, V., RESTA, F., CAVALIERE, R.L., LAROCCA, A., QUARTO, M., BRANDONISIO, O., ANGARANO, G., and PASTORE, G. (1998). Leishmaniosi viscerale in Puglia: indagine policentrica conoscitiva. Giornale Italiano delle Malattie Infettive, 4, 283-286.
8. NEVA, F.A., PONCE, C., PONCE, E., KREUTZER, R., MODABBER, F., and OLLIARO, P. (1997). Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 473-475.
9. PEARSON, R., and DE QUEIROZ SOUSA, A. (1994). Leishmania species: visceral (Kala-Azar), cutaneous and mucosal leishmaniasis. In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and Practice of Infectious Diseases. Churchill Livingstone Inc., New York , pp. 2428-2442.
10. SOTO, J., FUYA, P., HERRERA, R., and BERMAN, J. (1998). Topical paromomycin/methylbenzethonium chloride plus parental meglumine anti-moniate as treatment for American cutaneous leishmaniasis: controlled study. Clinical Infectious Diseases, 26, 56-58.
11. SOTO, J., HERNANDEZ, N., MEJIA, H., GROGL, M., and BERMAN, J. (1995). Successful treatment of New World Cutaneous Leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimoniate. Clinical Infectious Diseases, 20, 47-51.